De Bruin ML - Search Results

1

Global Regulatory Differences for Gene- and Cell-Based Therapies: Consequences and Implications for Patient Access and Therapeutic Innovation.

Coppens DGM, De Bruin ML, Leufkens HGM, Hoekman J. Coppens DGM, et al. Among authors: de bruin ml. Clin Pharmacol Ther. 2018 Jan;103(1):120-127. doi: 10.1002/cpt.894. Epub 2017 Nov 6. Clin Pharmacol Ther. 2018. PMID: 28983911 Review.

2

Use of sympathomimetic drugs leads to increased risk of hospitalization for arrhythmias in patients with congestive heart failure.

Bouvy ML, Heerdink ER, De Bruin ML, Herings RM, Leufkens HG, Hoes AW. Bouvy ML, et al. Among authors: de bruin ml. Arch Intern Med. 2000 Sep 11;160(16):2477-80. doi: 10.1001/archinte.160.16.2477. Arch Intern Med. 2000. PMID: 10979059

3

Use of cisapride with contraindicated drugs in The Netherlands.

De Bruin ML, Panneman MJ, Leufkens HG, Hoes AW, Herings RM. De Bruin ML, et al. Ann Pharmacother. 2002 Feb;36(2):338-43. doi: 10.1345/aph.1A246. Ann Pharmacother. 2002. PMID: 11847959

4

Non-sedating antihistamine drugs and cardiac arrhythmias -- biased risk estimates from spontaneous reporting systems?

De Bruin ML, van Puijenbroek EP, Egberts AC, Hoes AW, Leufkens HG. De Bruin ML, et al. Br J Clin Pharmacol. 2002 Apr;53(4):370-4. doi: 10.1046/j.1365-2125.2002.01569.x. Br J Clin Pharmacol. 2002. PMID: 11966667 Free PMC article.

5

QTc-prolonging drugs and hospitalizations for cardiac arrhythmias.

De Bruin ML, Hoes AW, Leufkens HG. De Bruin ML, et al. Am J Cardiol. 2003 Jan 1;91(1):59-62. doi: 10.1016/s0002-9149(02)02998-3. Am J Cardiol. 2003. PMID: 12505572

6

Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.

De Bruin ML, Pettersson M, Meyboom RH, Hoes AW, Leufkens HG. De Bruin ML, et al. Eur Heart J. 2005 Mar;26(6):590-7. doi: 10.1093/eurheartj/ehi092. Epub 2005 Jan 6. Eur Heart J. 2005. PMID: 15637086

7

Predicting cardiac arrhythmias and sudden death in diabetic users of proarrhythmic drugs.

De Bruin ML, van Staa TP, Belitser SV, Leufkens HG, Hoes AW. De Bruin ML, et al. Diabetes Care. 2005 Feb;28(2):440-2. doi: 10.2337/diacare.28.2.440. Diabetes Care. 2005. PMID: 15677812 No abstract available.

8

Hospital discharge diagnoses of ventricular arrhythmias and cardiac arrest were useful for epidemiologic research.

De Bruin ML, van Hemel NM, Leufkens HG, Hoes AW. De Bruin ML, et al. J Clin Epidemiol. 2005 Dec;58(12):1325-9. doi: 10.1016/j.jclinepi.2005.04.009. Epub 2005 Sep 12. J Clin Epidemiol. 2005. PMID: 16291479

9

Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data.

De Bruin ML, van Puijenbroek EP, Bracke M, Hoes AW, Leufkens HG. De Bruin ML, et al. Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):99-105. doi: 10.1002/pds.1194. Pharmacoepidemiol Drug Saf. 2006. PMID: 16329159

10

In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs.

De Bruin ML, Langendijk PN, Koopmans RP, Wilde AA, Leufkens HG, Hoes AW. De Bruin ML, et al. Br J Clin Pharmacol. 2007 Feb;63(2):216-23. doi: 10.1111/j.1365-2125.2006.02722.x. Epub 2006 Jul 21. Br J Clin Pharmacol. 2007. PMID: 16869820 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters